Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-18.96%Return on Assets
VS
Market
Sector
Industry
History
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information
Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQY-MABS THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
YMAB - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 117.21M | $ -22.22M | -18.96% |
| 3/31/2025 | $ 112.61M | $ -28.23M | -25.07% |
| 12/31/2024 | $ 119.9M | $ -29.67M | -24.74% |
| 9/30/2024 | $ 120.92M | $ -23.86M | -19.74% |
| 6/30/2024 | $ 144.03M | $ -24.61M | -17.09% |
| 3/31/2024 | $ 123.31M | $ -21.67M | -17.57% |
| 12/31/2023 | $ 127.87M | $ -21.43M | -16.76% |
| 9/30/2023 | $ 128.88M | $ -19.28M | -14.96% |
| 6/30/2023 | $ 132.4M | $ -39.06M | -29.5% |
| 3/31/2023 | $ 137.44M | $ -73.89M | -53.76% |
Key Performance Insights, Last 5 Years
- Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -85.58%.
- Over the past 5 years, Y-MABS THERAPEUTICS INC's average ROA has been -39.86%.
- The median ROA for Y-MABS THERAPEUTICS INC during this period was -24.91%
- Y-MABS THERAPEUTICS INC reached its highest ROA over the past 5 years at -14.96%.
- The lowest ROA recorded by Y-MABS THERAPEUTICS INC in the same timeframe -92.85%
Y-MABS THERAPEUTICS INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for Y-MABS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -122.54M ] / Assets [ $ 143.19M ]
(=) ROA [ -85.58% ] YMAB - Return on Assets, Last 5 years
-92.85%
Minimum
Sep 30, 2022
-14.96%
Maximum
Sep 30, 2023
-39.86%
Average
-24.91%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.45K |
|---|---|
| min | -33.42% |
| max | 33.98% |
| average | 0.1% |
| median | 1.53% |
| std | 10.63% |